Pharmaceutics 2027 conference
The Pharmaceutics 2027: From Biopharmaceutics to Clinical Pharmaceutics will take place in Barcelona, Spain from 28 to 30 June 2027. The following sessions are planned:
Tag: Controlled release
Cyclodextrins Meet Cosmetics, a review
The cosmetic industry is continuously evolving, searching for smarter and more efficient ways to deliver active ingredients with better stability,
Cyclodextrins as Multifunctional Platforms in Drug Delivery and Beyond: Structural Features, Functional Applications, and Future Trends
This review outlines the structural features of native CDs and their chemically modified derivatives, emphasizing the influence of functionalization on
Cyclodextrin-based rotaxanes as a versatile platform for biological and medicinal applications
Mechanically interlocked molecules (MIMs) such as rotaxanes and catenanes attract significant interest due to their unique structures and dynamic properties.
Hydrogel containing oxidized beta-cyclodextrin for in-vivo release of a medication: a sheep model
Cyclodextrins are seldom used in sustained-release formulations, as they are more commonly associated with rapid drug delivery. However, cyclodextrin complexes
Multifunctional Fluorescent β-cyclodextrin Hydrogel for pH-controlled Drug Release and Environmental Sensing
Smart biobased hydrogels have become increasingly significant in controlled drug delivery due to their ability to improve bioavailability and minimize
Cyclodextrins in 3D/4D printing for biomedical applications
Cyclodextrins (CDs) have only recently been explored as components of 3D printed objects despite the variety of functionalities they can
Beta-cyclodextrin containing theophylline formulation of rapid, but also prolonged adsorption profile: exploiting interaction characterized with Bs type of isotherm
Modi Mundi Pharma Pvt Ltd., India has developed a beta-cyclodextrin containing oral dosage form of 400 mg theophylline marketed under
Inclusion complexation and liposomal encapsulation of an isoniazid hydrazone derivative in cyclodextrin for pH-dependent controlled release
Tuberculosis, a predominantly pulmonary pathology, is currently the deadliest infection worldwide. Its treatment is based on combination therapy involving selected
Special Issue “Cyclodextrins: Properties and Applications”
Cyclodextrins (CDs) continue to attract the attention of a large group of researchers, interested mainly in their properties as complexing